Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 3Venous Thromboembolism 1Thoracic Neoplasms 1Solid Tumor 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Noonan Syndrome 1Neoplasms by Site 1Neoplasms 1Lung Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Healthy Participants 1Colorectal Neoplasms 1Carcinoma 1Bronchial Neoplasms 1Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation 1

Interventions

entinostat 3Carboplatin 3Pemetrexed 2Bronchoscopy 2sotorasib 1pralsetinib 1pembrolizumab 1osimertinib 1lorlatinib 1ficlatuzumab 1exemestane 1demcizumab 1cobimetinib 1camrelizumab 1aflibercept 1Tyrosine Kinase Inhibitors 1Thrombin 1Temozolomide 1TachoSil 1Saline Solution 1Radiomics 1Paclitaxel 1One-Lung Ventilation 1Nutritional Status 1Microscopy, Confocal 1Gefitinib 1Fibrinogen 1Exercise 1Erlotinib Hydrochloride 1Diagnostic Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lung Diseases × sotorasib × Clear all
NCT05054725 2026-01-06

Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

Revolution Medicines, Inc.

Phase 2 Completed
47 enrolled 17 charts
Thoracic

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Respiratory Tract Diseases, Respiratory Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡